News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mountain View Pharmaceuticals, Inc. Announces Receipt of a U.S. Patent on Next-Generation PEGylation Technology (PharmaPEG)



3/14/2012 7:09:40 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--Mountain View Pharmaceuticals, Inc. (“MVP”) announced today its receipt of U.S. Patent No. 8,129,330 B2 titled “Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES